These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29301479)

  • 1. Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study.
    Lindström L; Jørgensen KK; Boberg KM; Castedal M; Rasmussen A; Rostved AA; Isoniemi H; Bottai M; Bergquist A
    Scand J Gastroenterol; 2018 Mar; 53(3):297-304. PubMed ID: 29301479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients.
    Buchholz BM; Lykoudis PM; Ravikumar R; Pollok JM; Fusai GK
    World J Gastroenterol; 2018 Jul; 24(28):3171-3180. PubMed ID: 30065563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for recurrent primary sclerosing cholangitis after liver transplantation.
    Ravikumar R; Tsochatzis E; Jose S; Allison M; Athale A; Creamer F; Gunson B; Iyer V; Madanur M; Manas D; Monaco A; Mirza D; Owen N; Roberts K; Sen G; Srinivasan P; Wigmore S; Fusai G; Fernando B; Burroughs A
    J Hepatol; 2015 Nov; 63(5):1139-46. PubMed ID: 26186988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with
    Bajer L; Slavcev A; Macinga P; Sticova E; Brezina J; Roder M; Janousek R; Trunecka P; Spicak J; Drastich P
    World J Gastroenterol; 2018 Nov; 24(43):4939-4949. PubMed ID: 30487703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory conditions play a role in recurrence of PSC after liver transplantation: An international multicentre study.
    Visseren T; Erler NS; Heimbach JK; Eaton JE; Selzner N; Gulamhusein A; van der Heide F; Porte RJ; van Hoek B; Alwayn IPJ; Metselaar HJ; IJzermans JNM; Darwish Murad S
    JHEP Rep; 2022 Dec; 4(12):100599. PubMed ID: 36426376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipients.
    Venkat VL; Ranganathan S; Mazariegos GV; Sun Q; Sindhi R
    Liver Transpl; 2014 Jun; 20(6):679-86. PubMed ID: 24634351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.
    Alabraba E; Nightingale P; Gunson B; Hubscher S; Olliff S; Mirza D; Neuberger J
    Liver Transpl; 2009 Mar; 15(3):330-40. PubMed ID: 19243003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation--a single-centre experience.
    Moncrief KJ; Savu A; Ma MM; Bain VG; Wong WW; Tandon P
    Can J Gastroenterol; 2010 Jan; 24(1):40-6. PubMed ID: 20186355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC-IBD patients.
    Nordenvall C; Olén O; Nilsson PJ; von Seth E; Ekbom A; Bottai M; Myrelid P; Bergquist A
    Aliment Pharmacol Ther; 2018 Jan; 47(2):238-245. PubMed ID: 29064110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
    Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T
    Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes.
    Peverelle M; Paleri S; Hughes J; De Cruz P; Gow PJ
    Inflamm Bowel Dis; 2020 Nov; 26(12):1901-1908. PubMed ID: 31944235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation.
    Steenstraten IC; Sebib Korkmaz K; Trivedi PJ; Inderson A; van Hoek B; Rodriguez Girondo MDM; Maljaars PWJ
    Aliment Pharmacol Ther; 2019 Mar; 49(6):636-643. PubMed ID: 30740723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors.
    Brandsaeter B; Schrumpf E; Bentdal O; Brabrand K; Smith HJ; Abildgaard A; Clausen OP; Bjoro K
    Liver Transpl; 2005 Nov; 11(11):1361-9. PubMed ID: 16184522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of primary sclerosing cholangitis after liver transplantation - analysing the European Liver Transplant Registry and beyond.
    Visseren T; Erler NS; Polak WG; Adam R; Karam V; Vondran FWR; Ericzon BG; Thorburn D; IJzermans JNM; Paul A; van der Heide F; Taimr P; Nemec P; Pirenne J; Romagnoli R; Metselaar HJ; Darwish Murad S;
    Transpl Int; 2021 Aug; 34(8):1455-1467. PubMed ID: 34028110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.
    Cholongitas E; Shusang V; Papatheodoridis GV; Marelli L; Manousou P; Rolando N; Patch D; Rolles K; Davidson B; Burroughs AK
    Liver Transpl; 2008 Feb; 14(2):138-43. PubMed ID: 18236447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort.
    Liu K; Wang R; Kariyawasam V; Wells M; Strasser SI; McCaughan G; Corte C; Leong RW
    Liver Int; 2017 Mar; 37(3):442-448. PubMed ID: 27891750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.
    Gulamhusein AF; Eaton JE; Tabibian JH; Atkinson EJ; Juran BD; Lazaridis KN
    Am J Gastroenterol; 2016 May; 111(5):705-11. PubMed ID: 27002801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study.
    Jørgensen KK; Lindström L; Cvancarova M; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM
    Scand J Gastroenterol; 2012 Sep; 47(8-9):1021-9. PubMed ID: 22577871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.